These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6334796)

  • 21. [Beta-lactamase production and the patterns of bacterial resistance, 1988-1991].
    Rodríguez Noriega E; Morfín Otero R; Esparza Ahumada S
    Gac Med Mex; 1994; 130(5):355-60. PubMed ID: 7607365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and indirect pathogenicity of Branhamella catarrhalis.
    Brook I
    Drugs; 1986; 31 Suppl 3():97-102. PubMed ID: 3488202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of beta-lactamase production in gram-positive and gram-negative strains by sub-inhibitory concentrations of nalidixic acid.
    Repetto A; Scazzocchio F; Tiecco C; Renzini G
    Chemioterapia; 1984 Oct; 3(5):278-80. PubMed ID: 6335839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F; Lambert-Zechovsky N; Bingen E
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of extended-spectrum beta-lactamases in South America.
    Villegas MV; Kattan JN; Quinteros MG; Casellas JM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():154-8. PubMed ID: 18154539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemia.
    Wi YM; Kang CI; Cheong HS; Chung DR; Jung CW; Ko KS; Song JH; Peck KR
    Int J Antimicrob Agents; 2009 Apr; 33(4):384-6. PubMed ID: 19097866
    [No Abstract]   [Full Text] [Related]  

  • 27. [Detection of AmpC beta-lactamases in Gram-negative bacteria isolated from urine].
    Cernohorská L; Andrysík T
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):141-6. PubMed ID: 19069027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance patterns of selected respiratory tract pathogens in Poland.
    Skoczyńska A; Kadłubowski M; Waśko I; Fiett J; Hryniewicz W
    Clin Microbiol Infect; 2007 Apr; 13(4):377-83. PubMed ID: 17359321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of extended spectrum beta lactamases production with cephalosporin resistance in gram negative bacilli.
    Ghatole M; Manthalkar P; Kandle S; Yemul V; Jahagirdar V
    Indian J Pathol Microbiol; 2004 Jan; 47(1):82-4. PubMed ID: 15471144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinically important beta-lactamases of gram-negative bacteria: AmpC].
    Hrabák J
    Epidemiol Mikrobiol Imunol; 2007 Nov; 56(4):155-65. PubMed ID: 18064797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of moxifloxacin against community respiratory pathogens in Qatar.
    Elshafie SS; Al-Kuwari J
    Int J Antimicrob Agents; 2004 Sep; 24(3):309-10. PubMed ID: 15325441
    [No Abstract]   [Full Text] [Related]  

  • 32. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.
    Bush K
    Clin Infect Dis; 2001 Apr; 32(7):1085-9. PubMed ID: 11264037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current challenges in antimicrobial chemotherapy: the impact of extended-spectrum beta-lactamases and metallo-beta-lactamases on the treatment of resistant Gram-negative pathogens.
    Helfand MS; Bonomo RA
    Curr Opin Pharmacol; 2005 Oct; 5(5):452-8. PubMed ID: 16084766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchopulmonary infection due to Moraxella (Branhamella) catarrhalis at a specialist hospital in Saudi Arabia.
    Ahmad S
    J Commun Dis; 1998 Dec; 30(4):233-6. PubMed ID: 10810561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of clavulanic acid sulbactam on induction of class 1 beta-lactamase.
    Farmer TH; Reading C
    J Chemother; 1989 Jul; 1(4 Suppl):331-3. PubMed ID: 16312426
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of Moraxella catarrhalis infections of the lower respiratory tract in elderly patients.
    Tamang MD; Dey S; Makaju RK; Jha BK; Shivananda PG; Bhramadatan KN
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):39-44. PubMed ID: 16401943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid detection of extended-spectrum beta-lactamase (ESBL)-producing organisms in blood culture.
    Weinbren MJ; Borthwick MA
    J Antimicrob Chemother; 2005 Jan; 55(1):131-2. PubMed ID: 15574477
    [No Abstract]   [Full Text] [Related]  

  • 38. [Occurrence of Moraxella catarrhalis in patients with respiratory tract infections].
    Jakubicz P; Leszczyńska K
    Med Dosw Mikrobiol; 1997; 49(1-2):55-60. PubMed ID: 9411073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM
    Clin Infect Dis; 2005 Dec; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999.
    Marco F; García-de-Lomas J; García-Rey C; Bouza E; Aguilar L; Fernández-Mazarrasa C;
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3226-8. PubMed ID: 11600386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.